沙美特罗替卡松联合苏黄止咳胶囊治疗咳嗽变异性哮喘的效果研究  被引量:6

Study on Effect of Salmeterol Fluticasone Combined with Suhuang Zhike Capsules in Treatment of Cough Variant Asthma

在线阅读下载全文

作  者:柴霞[1] 宋艳丽[1] 赵蓬[1] 邹芳芳[1] 张柏林[1] CHAI Xia;SONG Yanli;ZHAO Peng;ZOU Fangfang;ZHANG Bolin(Deparment of Intemal Medicine Emergeney Tianjin First Hospital,Tianjin 300232China)

机构地区:[1]天津市第一医院内科急诊,天津300232

出  处:《中国药物滥用防治杂志》2022年第9期1317-1319,1323,共4页Chinese Journal of Drug Abuse Prevention and Treatment

基  金:天津市中医药管理局项目(编号:2017086)。

摘  要:目的:探讨沙美特罗替卡松联合苏黄止咳胶囊治疗咳嗽变异性哮喘(CVA)的疗效。方法:选取本院2019年3月—2021年3月就诊的咳嗽变异性哮喘患者72例作为研究对象,按照随机数字表法将其分为观察组和对照组,每组36例。对照组实施沙美特罗替卡松治疗,观察组则实施沙美特罗替卡松+苏黄止咳胶囊治疗,比较两组治疗效果、炎性因子水平及复发情况。结果:观察组治疗有效率为97.22%,高于对照组83.33%(P<0.05);观察组IL-6、IL-8、TNF-α水平低于对照组(P<0.05);随访3个月,观察组复发率为5.56%,低于对照组的22.22%(P<0.05)。结论:沙美特罗替卡松联合苏黄止咳胶囊治疗咳嗽变异性哮喘的疗效确切,可降低患者炎性因子水平,缓解临床症状,并延缓疾病复发,利于预后,值得临床应用。Objective:To investigate the efficacy of salmeterol fluticasone combined with Suhuang Zhike capsule in the treatment of cough variant asthma(CVA).Methods:A total of 72 patients with cough variant asthma who were treated in our hospital from March 2019 to March 2021 were selected as the research objects.They were divided into observation group and control group according to the random number table method,with 36 cases in each group.The control group was treated with salmeterol fluticasone,and the observation group was treated with salmeterol fluticasone+Suhuang Zhike capsule.The therapeutic effect,inflammatory factor level and recurrence were compared between the two groups.Results:The effective rate of the observation group was 97.22%,which was higher than 83.33%of the control group(P<0.05).The levels of IL6,IL-8 and TNF-αin the observation group were lower than those in the control group(P<0.05).After 3 months of followup,the recurrence rate of the observation group was 5.56%,which was lower than 22.22%of the control group(P<0.05).Conclusion:Salmeterol fluticasone propionate combined with Suhuang Zhike capsule is effective in the treatment of cough variant asthma.It can reduce the level of inflammatory factors,relieve clinical symptoms,delay the recurrence of the disease,and is beneficial to the prognosis.It is worthy of clinical application.

关 键 词:沙美特罗替卡松 苏黄止咳胶囊 咳嗽变异性哮喘 

分 类 号:R562.25[医药卫生—呼吸系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象